Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Viamet Pharmaceuticals Inc.
DescriptionSmall molecule inhibitor of cytochrome P450 C-14 alpha demethylase (CYP51)
Molecular Target Cytochrome P450 C-14 alpha demethylase (CYP51)
Mechanism of ActionCytochrome P450 C-14 alpha demethylase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationFungal infection
Indication DetailsTreat coccidioidomycosis (valley fever); Treat invasive fungal infections
Regulatory Designation U.S. - Orphan Drug (Treat coccidioidomycosis (valley fever));
U.S. - Qualified Infectious Disease Program (Treat coccidioidomycosis (valley fever))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today